Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ACTIVE NOT RECRUITING NA

Hypertonic Saline for Mild TBI in Pediatric Patients

NCT07060105 · View on ClinicalTrials.gov ↗

Study Summary

The purpose of this study is to compare two different treatments (normal saline and hypertonic saline) for concussions to see if one makes more of a difference in symptoms that can occur following concussions.

Interventions

  • OTHER Hypertonic Saline ( 3% Sodium Chloride Saline)
  • OTHER Normal Saline (0.9% NaCl)

Study Locations (1)

Texas

  • Dell Children's Medical Center — Austin

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2023-11-01
Est. Completion 2025-11-30
Phase NA

Sponsor

University of Texas at Austin

225 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07060105

The ClinicalTrials.gov registry entry for NCT07060105 describes a study currently listed as active not recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 225 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Pediatric appearing as the primary indexed condition, and to 2 interventions — of which Hypertonic Saline ( 3% Sodium Chloride Saline) is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT07060105 reports 1 study location spanning 1 distinct geographic area — top geographies include Texas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT07060105 about?

NCT07060105 is a clinical study titled "Hypertonic Saline for Mild TBI in Pediatric Patients". The purpose of this study is to compare two different treatments (normal saline and hypertonic saline) for concussions to see if one makes more of a difference in symptoms that can occur following concussions.

What is the current status of trial NCT07060105?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 74 participants. The study started on 2023-11-01. Estimated completion is 2025-11-30.

What conditions does trial NCT07060105 study?

This clinical trial studies the following conditions: Pediatric, Emergency Department Patient, Head Injury, Minor. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT07060105?

The interventions under investigation include: Hypertonic Saline ( 3% Sodium Chloride Saline) (OTHER), Normal Saline (0.9% NaCl) (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT07060105?

This trial is sponsored by University of Texas at Austin, which has 225 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT07060105 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial